A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009167/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This Phase IIb study in HIV-infected antiretroviral naive subjects will select an optimal
once daily dose of GSK1349572 from a range of doses for future evaluation.
提供机构：
Vivli
创建时间：
2023-08-15
